# FDA Inspection 1288702 - ACS Dobfar SpA - September 23, 2022

Source: https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/93aa4129-c9ed-48e9-b004-06c26fbfe8a2
Source feed: FDA_Inspections

> FDA Inspection 1288702 for ACS Dobfar SpA on September 23, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1288702
- Company Name: ACS Dobfar SpA
- Inspection Date: 2022-09-23
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1232886 - 2024-02-09](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/cb643859-6772-4d77-9c07-867f1a1467b4)
- [FDA Inspection 1128718 - 2018-12-14](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/7b541c41-6937-48dd-8467-3665486a26ad)
- [FDA Inspection 978122 - 2016-06-17](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/4309ab51-a6dd-4d59-a164-687872684b78)
- [FDA Inspection 871488 - 2014-03-28](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/10c681ae-1d12-4352-a06c-c605f76ccf5b)
- [FDA Inspection 871488 - 2014-03-28](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/efe1a2c3-2f5b-4664-9101-1e039ce72879)

Company: https://www.keypedia.com/companies/acs-dobfar-spa/d02d8bbd-7942-4a5d-a7a8-05fad27d9287

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c